Search

everythinglearnresearchcommunity

for

Search:↓

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Marine-derived ingredients show potential for hair health but need more human trials to confirm effectiveness.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Silver nanoparticles made from Ziziphus nummularia fruit extract promote hair growth and fight bacteria and fungi.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.